Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13)

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 9, 2008, Pages 1534-1541

  Tripodi, Armando ^a,i   Peyvandi, F ^a   Chantarangkul, V ^a   Palla, R ^a   Afrasiabi, A ^b   Canciani, M T ^a   Chung, D W ^c   Ferrari, S ^d   Fujimura, Y ^e   Karimi, M ^b   Kokame, K ^f   Kremer Hovinga, J A ^g   Lammle B ^g   De Meyer, S F ^h   Plaimauer, B ^d   Vanhoorelbeke, K ^h   Varadi, K ^d   Mannucci, P M ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF WASHINGTON   (United States)

^d BAXTER BIOSCIENCE   (Austria)

^e NARA MEDICAL UNIVERSITY   (Japan)

^f NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^g UNIVERSITY OF BERN   (Switzerland)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ NONE   (Italy)

Author keywords

Laboratory screening; Microangiopathies; Standardization; Thrombotic thrombocytopenic purpura; Von Willebrand factor

Indexed keywords

PEPTIDE DERIVATIVE; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ANALYSIS OF VARIANCE; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DILUTION; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME SUBSTRATE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LINEAR SYSTEM; MALE; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; REPRODUCIBILITY; STANDARDIZATION;

ADAM PROTEINS; COOPERATIVE BEHAVIOR; HUMANS; HYDROLYSIS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; VON WILLEBRAND FACTOR;

EID: 49849097124     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03099.x     Document Type: Article

References (19)

1. Gerritsen HE, Robles R, Lämmle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 2001; 98: 1654-61.
2. Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 2001; 98: 1662-6.
3. Furlan M, Robles R, Lämmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996; 87: 4223-34.
4. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1996; 87: 4235-44.
5. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997; 89: 3097-103.
6. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-94.
7. Tripodi A, Chantarangkul V, Böhm M, Budde U, Dong J-f, Friedman KD, Galbusera M, Girma J-P, Moake J, Rick ME, Studt J-D, Turecek PL, Mannucci PM. Measurement of von Willebrand factor cleaving protease (ADAMTS-13). Results of an international collaborative study involving eleven methods testing the same set of coded plasmas. J Thromb Haemost 2004; 2: 1601-9.
8. Gerritsen HE, Turecek PL, Schwarz HP, Lämmle B, Furlan M. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost 1999;82: 1386-9.
9. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-84.
10. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS-13 assay. Br J Haematol 2005; 129: 93-100.
11. Feys HB, Liu F, Dong N, Parein I, Vauterin S, Vandeputte N, Noppe W, Ruan C, Deckmyn H, Vanhoorelbeke K. ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences. J Thromb Haemost 2006; 4: 955-62.
12. Peyvandi F, Ferrari S, Lavoretano S, Canciani MT, Mannucci PM. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing antibodies in 100 patients with thrombotic thrombocytopenic purpura. Br J Haematol 2004; 127: 433-9.
13. Bohm M, Vigh T, Scharrer I. Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13). Ann Hematol 2002; 81: 430-5.
14. Kremer Hovinga JA, Mottini M, Lämmle B. Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: Comparison with other methods. J Thromb Haemost 2006; 4: 1146-8.
15. Kato S, Matsumoto M, Matsuyama T, Isonishi A, Hiura H, Fujimura Y. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS-13 activity. Transfusion 2006; 46: 1444-52.
16. Wu J-J, Fujikawa K, Lian EC, Mcmullen BA, Kulman JD, Chung DW. A rapid enzyme-linked assay for ADAMTS-13. J Thromb Haemost 2006; 4: 129-36.
17. Rieger M, Ferrari S, Kremer Hovinga JA, Konetschny C, Herzog A, Koller L, Weber A, Remuzzi G, Dockal M, Plaimauer B, Scheiflinger F. Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA). Thromb Haemost 2006; 95: 212-20.
18. Kostousov V, Fehr J, Bombeli T. Novel semi-automated, 60-min assay to determine von Willebrand factor cleaving activity of ADAMTS-13. Thromb Res 2006; 118: 723-31.
19. Jin M, Cataland S, Bissell M, Wu HM. A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionisation- time-of-flight (SELDI-TOF)-mass spectrometry. J Thromb Haemost 2006; 4: 333-8.